Another Successful INVENTED at DUKE

MesnAR

From Drug-Resistant AI to AR Brain Models–Duke Puts its Innovative Spirit on Display Again

Learn more

Another Successful INVENTED at DUKE
From Drug-Resistant AI to 3D Printed Sports Pads –Duke Puts its Innovative Spirit on Display Again

Duke Innovations: OLV Annual Report

FY19 Annual Report Numbers

A record-setting year of innovation — In FY19 we saw researchers from across campus working with our team to break records for the number of inventions, agreements, and exclusive license deals.

Duke Innovations: OLV Annual Report
A record-setting year of innovation — In FY19 we saw researchers from across campus working with our team to break records for the number of inventions, agreements, and exclusive license deals.

Learn More

NIH funding
RTP #1 in Nation for
NIH Per-Capita Funding

Last year the Triangle had more than 2,500 NIH grants, totaling~$1.5 billion–with UNC and Duke awarded 1,700+ awards at ~$1 billion.

Learn more

REGIONAL NEWS

RTP #1 in Nation for NIH Per-Capita Funding
Last year the Triangle had more than 2,500 NIH grants, totaling~$1.5 billion–with UNC and Duke awarded 1,700+ awards at ~$1 billion.

Precision Biosciences IPO

Precision BioSciences

Launches IPO

The Duke start-up closed on its initial public offering of 9,085,000 shares of common stock this April. The total gross proceeds to Precision were approximately $145.4 million.

Learn More

TECH TRANSFER NEWS

Precision BioSciences: Launches IPO
The Duke start-up closed on its initial public offering of 9,085,000 shares of common stock this April. The total gross proceeds to Precision were approximately $145.4 million.

OLV on the HILL: Women in Innovation

OLV Exec. Dir Robin Rasor testifying before Senate IP Subcommittee April 3rd, 2019

On April 3rd, Exec. Director Robin Rasor testified before the Senate Subcommittee on IP about the uniqueness of Duke’s model and how to encourage and retain women in STEM.

Read more
OLV on the HILL: Women in Innovation
On April 3rd, Exec. Director Robin Rasor testified before the Senate Subcommittee on IP about the uniqueness of Duke’s model and how to encourage and retain women in STEM.

From Idea to Industry

The Office of Licensing and Ventures (OLV) is the licensing and venture creation arm of Duke University

Take the first step
Road map Created with Sketch. Revenue received from licensing is distributed to inventors, the inventors’ primary department, and Duke University for investment in future research . We market and license the technology to an existing business, or assist you in creating a new entity as a licensee (a “start-up”). We work with you to identify resources for you or third parties to continue development of your invention to de-risk it further for commercialization. In consultation with you, we determine the best method for protecting your invention, usually via patent or copyright protection. We assess your invention using criteria including patentability, stage of development, and marketability. Submit your invention using a Disclosure Form (see above for link) or contact us for a pre-disclosure meeting. Where it all begins: the raw material behind your potential ideas and inventions.

From Idea to Industry

The Office of Licensing and Ventures (OLV) is the licensing and venture creation arm of Duke University

Take the first step

From Idea to Industry

The Office of Licensing and Ventures (OLV) is the licensing and venture creation arm of Duke University

Take the first step
 

Faculty & Innovators

Start here

Industry & Investors

START HERE

Resources

START HERE